Progyny, Inc. (NASDAQ:PGNY – Get Free Report) Director Cheryl Scott sold 1,462 shares of the company’s stock in a transaction that occurred on Friday, June 28th. The shares were sold at an average price of $28.39, for a total value of $41,506.18. Following the completion of the sale, the director now owns 10,098 shares in the company, valued at $286,682.22. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Progyny Stock Down 0.8 %
NASDAQ PGNY traded down $0.23 on Monday, reaching $28.38. The company had a trading volume of 1,243,484 shares, compared to its average volume of 971,181. The stock has a market capitalization of $2.70 billion, a P/E ratio of 46.90, a P/E/G ratio of 1.85 and a beta of 1.46. The company’s fifty day moving average is $28.62 and its 200 day moving average is $34.19. Progyny, Inc. has a 52-week low of $23.90 and a 52-week high of $44.95.
Progyny (NASDAQ:PGNY – Get Free Report) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.03. The business had revenue of $278.08 million during the quarter, compared to analyst estimates of $289.41 million. Progyny had a return on equity of 11.61% and a net margin of 5.53%. Progyny’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.18 EPS. On average, research analysts expect that Progyny, Inc. will post 0.73 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Report on Progyny
Institutional Investors Weigh In On Progyny
Institutional investors and hedge funds have recently bought and sold shares of the stock. Parkside Financial Bank & Trust grew its stake in Progyny by 9.3% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,096 shares of the company’s stock valued at $115,000 after purchasing an additional 264 shares during the period. Caprock Group LLC grew its stake in shares of Progyny by 5.3% during the 1st quarter. Caprock Group LLC now owns 6,288 shares of the company’s stock worth $240,000 after acquiring an additional 319 shares during the period. RiverPark Advisors LLC grew its stake in shares of Progyny by 54.0% during the 4th quarter. RiverPark Advisors LLC now owns 1,067 shares of the company’s stock worth $40,000 after acquiring an additional 374 shares during the period. M&G Investment Management Ltd. grew its stake in shares of Progyny by 1.2% during the 4th quarter. M&G Investment Management Ltd. now owns 32,980 shares of the company’s stock worth $1,220,000 after acquiring an additional 387 shares during the period. Finally, FourThought Financial Partners LLC grew its stake in shares of Progyny by 1.3% during the 4th quarter. FourThought Financial Partners LLC now owns 32,683 shares of the company’s stock worth $1,215,000 after acquiring an additional 423 shares during the period. 94.93% of the stock is owned by hedge funds and other institutional investors.
Progyny Company Profile
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Featured Stories
- Five stocks we like better than Progyny
- 3 Tickers Leading a Meme Stock Revival
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- How to Invest in Insurance Companies: A GuideĀ
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.